Individual hospitals all over the U.S. have responded to the president's attacks on transgender healthcare by deciding to ...
Explore the scores and performances of each bC1 in boccia. Follow the full results of the Paris 2024 Paralympics with Le ...
Morning Overview on MSN
A year of added prostate-cancer therapy cut the odds the disease spreads, a major trial found
Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...
Clinical data reveals male factors contribute to half of all infertility cases, shifting the focus toward earlier ...
The high court ruled a Texas woman who regretted a surgery she underwent as part of her gender transition initiated legal ...
The "TikTok Medical Group" has stirred the viral waters around biohacking male infertility. GLP-1 receptor agonists are ...
Crinetics Pharmaceuticals stock is a 'Buy' rating due to EU approval and strong initial U.S. uptake of Palsonify for ...
Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, ...
KyneRx has officially launched its nationwide telehealth platform, expanding access to personalized hormone optimization services for adults seeking convenient, physician-guided care from the comfort ...
Marius Pharmaceuticals has backed a move by the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to update prescribing information for testosterone ...
The Department of Health and Human Services (HHS) announced plans on June 18 to update label information for testosterone ...
The U.S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results